Episode Details
Back to Episodes
Episode 194 ESMO 2022: Pegylated il-2 + nivolumab in renal cancer
Season 1
Episode 194
Published 4 years, 1 month ago
Description
Nizar Tannir describes this randomised phase 3 study presented at ESMO.